Letaplimab
- Generic Name
- Letaplimab
- Drug Type
- Biotech
- CAS Number
- 2283356-07-8
- Unique Ingredient Identifier
- BDN84I1TFE
- Background
Letaplimab is under investigation in clinical trial NCT04485052 (Efficacy and Safety Evaluation of IBI188 in Combination With Azacitidine in Treatment of Patients With Acute Myeloid Leukemia).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath